Legislator Case Law & Legislation
810.21 CH AI generated

Art. 36 Federal Act of 8 October 2004 on the Transplantation of Organs, Tissues and Cells (Act)

Act; Chapter 2 Human Organs, Tissues and Cells
Open official source Full Act (78 Articles) Machine-readable Markdown (.md)

Legislator summary

AI generated

Clinical trials involving the transplantation of human organs, tissues or cells require authorisation from the FOPH in advance. For certain trials, the Federal Council may grant an exemption from mandatory authorisation or specify mandatory notification. The FOPH shall determine whether the organs, tissues or cells used in a clinical trial meet the requirements specified in this Act. It may inspect clinical trials at any time. The Federal Council shall issue regulations concerning the procedure. It may specify mandatory authorisation for changes to clinical trials. It may specify notification or information requirements, in particular with regard to: a. the completion or discontinuation of a clinical trial; b. adverse events observed in connection with a clinical trial; c. the occurrence of circumstances during the conduct of a clinical trial which could affect the safety or health of the participants. In issuing regulations in accordance with paragraphs 3 and 4, the Federal Council shall have regard to recognised international regulations. For clinical trials, the Human Research Act of 30 September 2011 {note: SR 810.30} is also applicable.

Art. 36 Act

Clinical trials involving the transplantation of human organs, tissues or cells require authorisation from the FOPH in advance. For certain trials, the Federal Council may grant an exemption from mandatory authorisation or specify mandatory notification.

The FOPH shall determine whether the organs, tissues or cells used in a clinical trial meet the requirements specified in this Act. It may inspect clinical trials at any time.

The Federal Council shall issue regulations concerning the procedure. It may specify mandatory authorisation for changes to clinical trials.

It may specify notification or information requirements, in particular with regard to: a. the completion or discontinuation of a clinical trial; b. adverse events observed in connection with a clinical trial; c. the occurrence of circumstances during the conduct of a clinical trial which could affect the safety or health of the participants.

In issuing regulations in accordance with paragraphs 3 and 4, the Federal Council shall have regard to recognised international regulations.

For clinical trials, the Human Research Act of 30 September 2011 is also applicable.

← Art. 35 Act Federal Act of 8 October 2004 on the Transplantation of Organs, Tissues and Cells (Act) - Aim Art. 37 Act →

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →